BR0112452A - Derivados de pleuromutilinas tendo atividade antibacteriana - Google Patents

Derivados de pleuromutilinas tendo atividade antibacteriana

Info

Publication number
BR0112452A
BR0112452A BR0112452-8A BR0112452A BR0112452A BR 0112452 A BR0112452 A BR 0112452A BR 0112452 A BR0112452 A BR 0112452A BR 0112452 A BR0112452 A BR 0112452A
Authority
BR
Brazil
Prior art keywords
derivatives
antibacterial activity
pleuromutilins
acetyl
mutilines
Prior art date
Application number
BR0112452-8A
Other languages
English (en)
Other versions
BRPI0112452B1 (pt
BRPI0112452B8 (pt
Inventor
Gerd Ascher
Heinz Berner
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of BR0112452A publication Critical patent/BR0112452A/pt
Publication of BRPI0112452B1 publication Critical patent/BRPI0112452B1/pt
Publication of BRPI0112452B8 publication Critical patent/BRPI0112452B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/53Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/93Spiro compounds
    • C07C2603/95Spiro compounds containing "not free" spiro atoms
    • C07C2603/98Spiro compounds containing "not free" spiro atoms containing at least one ring with more than six ring members
    • C07C2603/99Spiro compounds containing "not free" spiro atoms containing at least one ring with more than six ring members containing eight-membered rings

Abstract

"DERIVADOS DE PLEUROMUTILINAS TENDO ATIVIDADE ANTIBACTERIANA". Composto selecionado entre 14-O-[(cicloalquil-sulfanil)acetil]-mutilinas; 14-O-[(cicloalquil-alquil-sulfanil)acetil]mutilinas; 14-O-[(cicloalcóxi)-acetil]mutilinas; ou 14-O-[(cicloalqu
BRPI0112452A 2000-07-11 2001-07-09 derivados de pleuromutilinas tendo atividade antibacteriana e composição farmacêutica contendo os mesmos BRPI0112452B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017031.6A GB0017031D0 (en) 2000-07-11 2000-07-11 Antimicrobials
PCT/EP2001/007875 WO2002004414A1 (en) 2000-07-11 2001-07-09 Pleuromutilin derivatives having antibacterial activity

Publications (3)

Publication Number Publication Date
BR0112452A true BR0112452A (pt) 2003-07-22
BRPI0112452B1 BRPI0112452B1 (pt) 2015-06-09
BRPI0112452B8 BRPI0112452B8 (pt) 2021-05-25

Family

ID=9895454

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0112452A BRPI0112452B8 (pt) 2000-07-11 2001-07-09 derivados de pleuromutilinas tendo atividade antibacteriana e composição farmacêutica contendo os mesmos

Country Status (29)

Country Link
US (1) US6753445B2 (pt)
EP (1) EP1305282B1 (pt)
JP (2) JP4255282B2 (pt)
KR (1) KR100893426B1 (pt)
CN (1) CN1308301C (pt)
AR (1) AR029590A1 (pt)
AT (1) ATE408596T1 (pt)
AU (2) AU7638901A (pt)
BR (1) BRPI0112452B8 (pt)
CA (1) CA2412932C (pt)
CZ (1) CZ200342A3 (pt)
DE (1) DE60135848D1 (pt)
EC (1) ECSP024400A (pt)
ES (1) ES2313969T3 (pt)
GB (1) GB0017031D0 (pt)
HK (1) HK1052683B (pt)
HU (1) HU229510B1 (pt)
IL (2) IL153839A0 (pt)
MX (1) MXPA02012828A (pt)
NO (1) NO329091B1 (pt)
NZ (1) NZ523415A (pt)
PE (1) PE20020144A1 (pt)
PL (1) PL209305B1 (pt)
RU (1) RU2003103101A (pt)
SI (1) SI1305282T1 (pt)
SK (1) SK292003A3 (pt)
TW (1) TWI311552B (pt)
WO (1) WO2002004414A1 (pt)
ZA (1) ZA200300280B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0017031D0 (en) 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
GB0207495D0 (en) * 2002-03-28 2002-05-08 Biochemie Gmbh Organic compounds
GB0209262D0 (en) 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
EP2298733B1 (en) * 2005-06-27 2016-05-25 Nabriva Therapeutics AG Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group
GB0513058D0 (en) * 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
GB0515995D0 (en) 2005-08-03 2005-09-07 Sandoz Ag Organic compounds
EP1808431A1 (en) * 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin derivatives and their use as pharmaceutical
EP1972618A1 (en) 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin derivatives for the treatment of diseases mediated by microbes
US8222407B2 (en) 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
EP2159220A1 (en) 2008-09-02 2010-03-03 Nabriva Therapeutics AG Organic compounds
CN101671367B (zh) * 2008-09-12 2012-09-05 中国科学院上海药物研究所 截短侧耳素磷酸酯类化合物、其药物组合物及其制备方法和用途
WO2010056855A1 (en) * 2008-11-13 2010-05-20 Teva Pharmaceutical Industries Ltd. Preparation of retapamulin via its pleuromutilin-thiol precursor
EP2399904A1 (en) * 2010-05-26 2011-12-28 Nabriva Therapeutics AG Process for the preparation of pleuromutilins
CN103204787B (zh) * 2012-01-17 2014-10-01 北京艾百诺科技有限公司 含有取代方酸的乙酸妙林酯及其应用
CN102924350B (zh) * 2012-10-31 2014-04-09 中国农业科学院兰州畜牧与兽药研究所 截短侧耳素衍生物及其制备方法和应用
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
US11518740B2 (en) * 2021-04-24 2022-12-06 Shaanxi University Of Science And Technology Pleuromutilin (phenylthio)acetic acid ester with anti-drug resistant bacteria activity and a method of preparing the same
CN115850137B (zh) * 2022-11-12 2024-04-12 中国农业科学院兰州畜牧与兽药研究所 一种截短侧耳素衍生化合物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT301753B (de) * 1969-07-25 1972-09-25 Biochemie Gmbh Verfahren zur Herstellung neuer Pleuromutilin-Derivate
BE789629A (fr) * 1971-10-05 1973-04-03 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
BE896512A (fr) * 1982-04-28 1983-10-20 Sandoz Ag Nouveaux derives de la pleuromutiline, leur preparation et leur utilisation comme medicaments
FR2526019A1 (fr) * 1982-04-28 1983-11-04 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leur utilisation comme medicaments
DE3560511D1 (en) * 1984-02-17 1987-10-01 Sandoz Ag Pleuromutilin derivatives, process for their preparation and their use
HU208115B (en) * 1989-10-03 1993-08-30 Biochemie Gmbh New process for producting pleuromutilin derivatives
JP3054875B2 (ja) * 1995-02-13 2000-06-19 株式会社小松製作所 プラズマトーチ
GB9614017D0 (en) * 1996-07-04 1996-09-04 Biochemie Gmbh Organic compounds
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
WO2000027790A1 (en) 1998-11-11 2000-05-18 Smithkline Beecham P.L.C. Mutilin compounds
GB0017031D0 (en) 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials

Also Published As

Publication number Publication date
IL153839A0 (en) 2003-07-31
CN1308301C (zh) 2007-04-04
TWI311552B (en) 2009-07-01
JP4255282B2 (ja) 2009-04-15
JP2004502755A (ja) 2004-01-29
EP1305282A1 (en) 2003-05-02
DE60135848D1 (de) 2008-10-30
CA2412932C (en) 2011-01-04
WO2002004414A1 (en) 2002-01-17
NZ523415A (en) 2004-10-29
BRPI0112452B1 (pt) 2015-06-09
ECSP024400A (es) 2003-02-06
NO329091B1 (no) 2010-08-23
AR029590A1 (es) 2003-07-02
CN1441778A (zh) 2003-09-10
US20030162831A1 (en) 2003-08-28
JP5173763B2 (ja) 2013-04-03
GB0017031D0 (en) 2000-08-30
IL153839A (en) 2012-03-29
HK1052683A1 (en) 2003-09-26
NO20030100D0 (no) 2003-01-09
MXPA02012828A (es) 2003-09-05
CZ200342A3 (cs) 2003-04-16
RU2003103101A (ru) 2004-07-27
ES2313969T3 (es) 2009-03-16
PE20020144A1 (es) 2002-03-08
KR100893426B1 (ko) 2009-04-17
PL209305B1 (pl) 2011-08-31
JP2009108088A (ja) 2009-05-21
BRPI0112452B8 (pt) 2021-05-25
AU7638901A (en) 2002-01-21
EP1305282B1 (en) 2008-09-17
ATE408596T1 (de) 2008-10-15
CA2412932A1 (en) 2002-01-17
HK1052683B (zh) 2009-05-22
SI1305282T1 (sl) 2009-02-28
AU2001276389B2 (en) 2005-03-03
NO20030100L (no) 2003-01-09
ZA200300280B (en) 2004-04-08
PL358674A1 (en) 2004-08-09
HU229510B1 (en) 2014-01-28
SK292003A3 (en) 2003-07-01
KR20030066581A (ko) 2003-08-09
HUP0301478A2 (hu) 2003-09-29
HUP0301478A3 (en) 2006-02-28
US6753445B2 (en) 2004-06-22

Similar Documents

Publication Publication Date Title
BR0112452A (pt) Derivados de pleuromutilinas tendo atividade antibacteriana
IL124593A0 (en) Substituted aryl or heteroarylamides having retinoid-like biological activity
PT1028961E (pt) Derivados de pleuromutilina como agentes antimicrobianos
ES2180899T3 (es) Dihidrato d de olanzapina.
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
ATE275151T1 (de) 3,6-ketal-makrolidantibiotika
MX9800625A (es) Marcfortinas y paraherquamidas antiparasitarias.
NO20011738L (no) Heterocyclylaminometyloksazolidinoner som antibakterielle midler
PT877750E (pt) 2-azetidinonas substituidas por acucar uteis como agentes hipocolesterolemiantes
DK0869949T3 (da) Benzoxaziner som antimikrobielle midler
BR9913225A (pt) Novos agentes antibacterianos de isoxazolinona
DE69300694T2 (de) Desinfizierende Zusammensetzungen.
HRP20010238B1 (en) 2-methyl-thieno-benzodiazepine formulation
DE69626754D1 (de) Wässrige, vernetzbare Zusammensetzungen
AU1560200A (en) Disinfecting agents
EP1073447A4 (en) N1-MODIFIED GLYCOPEPTIDES
IT1307018B1 (it) Agenti antibatterici.
DE69725459D1 (de) Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane
AU2645699A (en) Aqueous disinfecting solution
TR199801835A3 (tr) Antimikrobiyal kompozisyonlar.
BR9708029A (pt) Uma enxima.
FR2696643B1 (fr) Dispersat purifiant désinfectant odorisant.
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
DE69717147D1 (en) Thrombin inhibitoren
ZA991412B (en) Derivatives of glycopeptide antibacterial agents.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: BIOCHEMIE GMBH (AT)

Free format text: NOME ALTERADO DE: BIOCHEMIE GESELLSCHAFT M.B.H.

B25D Requested change of name of applicant approved

Owner name: SANDOZ GMBH (AT)

Free format text: NOME ALTERADO DE: BIOCHEMIE GMBH

B25A Requested transfer of rights approved

Owner name: NABRIVA THERAPEUTICS AG (AT)

Free format text: TRANSFERIDO DE: SANDOZ GMBH

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/06/2015, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved
B25G Requested change of headquarter approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/07/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2678 DE 03-05-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.